Biocartis Group NV announced the appointment of George Cardoza as its new Chief Financial Officer effective as of 7 August 2023. In this key executive role, Mr. Cardoza will be responsible for overseeing the Company's financial strategies, driving operational efficiencies, and ensuring sustainable growth in line with the organization's objectives. In addition, Mr. Cardoza will oversee the execution of Biocartis?

strategic partnerships, including those with pharmaceutical and diagnostic companies. Mr. Cardoza has more than 25 years of experience in the diagnostics and laboratory industry, and brings a unique combination of extensive experience in both finance and operational leadership roles. Prior to joining Biocartis, Mr. Cardoza served as CEO of AccuraGen Holdings LLC and prior to that he served in various executive roles (President and Chief Operating Officer Laboratory Services, President Pharma Services Division, and CFO) at NeoGenomics Laboratories.

Throughout his career, Mr. Cardoza has demonstrated a strong aptitude for financial management, strategic planning, and fostering collaboration across departments. He possesses a deep understanding of the industry landscape and a proven ability to navigate complex financial challenges while driving profitability. Mr. Cardoza holds a B.S. in Finance and Accounting from Syracuse University and an MBA from Michigan State University.